Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study
- Resource Type
- Article
- Authors
- Matulonis, U.A. ; Shapira-Frommer, R.; Santin, A.D.; Lisyanskaya, A.S.; Pignata, S.; Vergote, I.; Raspagliesi, F.; Sonke, G.S.; Birrer, M.; Provencher, D.M.; Sehouli, J.; Colombo, N.; González-Martín, A.; Oaknin, A.; Ottevanger, P.B.; Rudaitis, V.; Katchar, K.; Wu, H.; Keefe, S.; Ruman, J.; Ledermann, J.A.
- Source
- In Annals of Oncology July 2019 30(7):1080-1087
- Subject
- Language
- ISSN
- 0923-7534